Pharma Journalist -

Amgen announced that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for Aimovig (erenumab) for the suppression of onset of migraine attacks in…
Read More...

AbCellera announced it has secured a site in Vancouver for the construction of a Good Manufacturing Practices (GMP) manufacturing facility for the production of therapeutic antibodies,…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Commission has purchased an additional 150 million doses of…
Read More...

IMMUNOPRECISE ANTIBODIES LTD the market leader in full-service therapeutic discovery and development and Eurofins Discovery, the leading provider of products and services to the drug…
Read More...

Fujitsu Japan Limited announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of Research Center for Advanced…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, and Halozyme Therapeutics, Inc.…
Read More...

Grace Science, LLC announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GS-100, an investigational AAV9 gene replacement therapy for the…
Read More...

SMi Group reports: Speakers confirmed for the 2nd annual Wearable Injectors and Connected Devices Conference 2021 which will convene 18th – 19th October. The Wearable Injectors and…
Read More...

SMi Reports: Exploring therapeutic applications of connected on-body devices at Inaugural Medical Wearables for Biosensors Conference Boston, USA. As part of SMi’s leading series of…
Read More...

Biotage is pleased to announce the launch of Biotage PhyPrep, a new automated platform for plasmid DNA purification that releases laboratory staff from the tedium of repetitive, manual…
Read More...